The quantity and quality of scientific graphs in pharmaceutical advertisements

Journal of General Internal Medicine

Volumn 18, Issue 4, 2003, Pages 294-297

  Cooper, Richelle J ^a,c   Schriger, David L ^a   Wallace, Roger C ^a   Mikulich, Vladislav J ^a   Wilkes, Michael S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

Advertising standards; Drug industry; Graphing; Medical illustration

Indexed keywords

ADVERTIZING; ARTICLE; DRUG INDUSTRY; DRUG MARKETING; MEDICAL LITERATURE; MEDICAL PHOTOGRAPHY; PUBLICATION; STANDARD;

EID: 0038298719     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.2003.20703.x     Document Type: Article

References (20)

1. th Anniversary ed. New York, NY: Basic Books; 2001.
2. Cooper RJ, Schriger DL, Tashman DA. An evaluation of the graphical literacy of the Annals of Emergency Medicine. Ann Emerg Med. 2001;37:13-9.
3. Cooper RJ, Schriger DL, Close RJH. Graphical literacy: the quality of graphs in a large-circulation journal. Ann Emerg Med. 2002;40:317-22.
4. Tufte ER. Multifunctioning graphical elements. In: Tufte ER. Visual Display of Quantitative Information. Cheshire, Conn: Graphic Press: 1983:139-59.
5. Tufte ER. Data density and small multiples. In Tufte ER. Visual Display of Quantitative Information. Cheshire. Conn: Graphic Press; 1983:170-75.
6. Tufte ER. Small multiples. In Tufte ER. Envisioning Information. Cheshire, Conn: Graphic Press: 1990:67-80.
7. Schriger DL, Cooper RJ. Achieving graphical excellence: suggestions and methods for creating high-quality visual displays of experimental data. Ann Emerg Med. 2001;37:75-87.
8. Tufte ER. Chartjunk: vibrations, grids, and ducks. In: Tufte ER. Visual Display of Quantitative Information. Cheshire. Conn: Graphic Press; 1983:107-21.
9. Code of Federal Regulations, Title 21, Vol 4. Food and Drugs. Part 202, Prescription Drug Advertising, Revised. Washington, DC: US Government Printing Office; 2001.
10. Beary JF, Pharmaceutical marketing has real and proven value. J Gen Intern Med. 1996;11:635-6.
11. Ferner RE, Scott DK, Whatalotwegot-the messages in drug advertisements. 1994;309:1734-6.
12. Cleveland WS. Visualizing Data. Summit, NJ: Hobart Press; 1993.
13. Tufte ER. Visual Display of Quantitative Information. Cheshire, Conn: Graphic Press; 1983.
14. Gutknecht DR, Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract. 2001;14:197-200.
15. Wilkes MS, Doblin BH. Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med. 1992;116:912-9.
16. Rothermich EA, Pathak DS, Smeenk DA. Health-related quality-of-life claims in prescription drug advertisements. Am J Health Syst Pharm. 1996;53:1565-9.
17. Kessler DA, Addressing the problem of misleading advertising. Ann Intern Med. 1992:116:950-1.
18. Wilkes MS, Kravitz RL. Policies, practices, and attitudes of North American medical journal editors. J Gen Intern Med. 1995;10:443-50.
19. Fourth International Congress on Peer-Review in Biomedical Publication. 2001. Polling of the audience occurred as part of the discussion of the oral presentation of this abstract. Available at: http://www.ama-assn.org/public/peer/prc_program2001. htm#ABSTRACTS. Accessed October 20, 2002.
20. Angel JE. Drug advertisements and prescribing. Lancet. 1996;348:1452-3.